Literature DB >> 10580635

The immune system in the elderly: I. Specific humoral immunity.

L Ginaldi1, M De Martinis, A D'Ostilio, L Marini, M F Loreto, M P Corsi, D Quaglino.   

Abstract

Profound and complex changes in the immune response occur during the aging process. Immunosenescence is reflected by a sum of disregulations of the immune system and its interaction with other systems. Many of the changes would appear to implicate age-related deficiencies of the immune responses. The term immunosenescence designates therefore a sort of deterioration of the immune function which is believed to manifest itself in the increased susceptibility to cancer, autoimmune disease, and infectious disease. Evidence has been accumulating from several studies which suggest an association between immune function and individual longevity. However, there are observations, especially in very old healthy people, that several immune functions are unexpectedly well preserved and substantially comparable to those observed in young subjects. These findings raise the question of whether the alterations that can be observed in the immune parameters of the elderly are a cause or a result of underlying disease processes. Moreover, studies on centenarians revealed a remodeling of the immune system rather than a deterioration, suggesting that the changes observed during immunosenescence do not correspond to immunodeficiency. The underlying mechanisms of these events are however still unclear. The purpose of the present review is to assess the status of research on the immunobiology of aging. In this first section, we focus attention on the B cell biology of aging. In clinical practice, the changes in humoral immune responsiveness and antibody-mediated defense mechanisms could greatly influence the incidence and outcome of bacterial infections and autoimmune diseases as well as the response to vaccines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580635     DOI: 10.1007/BF02786466

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  62 in total

1.  Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population.

Authors:  R Paganelli; I Quinti; U Fagiolo; A Cossarizza; C Ortolani; E Guerra; P Sansoni; L P Pucillo; E Scala; E Cozzi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

Review 2.  Senescence, immortalization, and apoptosis. An intriguing relationship.

Authors:  D Monti; E Grassilli; L Troiano; A Cossarizza; S Salvioli; D Barbieri; C Agnesini; S Bettuzzi; M C Ingletti; A Corti
Journal:  Ann N Y Acad Sci       Date:  1992-12-26       Impact factor: 5.691

Review 3.  An attempt at a rational classification of theories of ageing.

Authors:  Z A Medvedev
Journal:  Biol Rev Camb Philos Soc       Date:  1990-08

Review 4.  Nutritional regulation of immunity and risk of infection in old age.

Authors:  R K Chandra
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

5.  Admission criteria for immunogerontological studies in man: the SENIEUR protocol.

Authors:  G J Ligthart; J X Corberand; C Fournier; P Galanaud; W Hijmans; B Kennes; H K Müller-Hermelink; G G Steinmann
Journal:  Mech Ageing Dev       Date:  1984-11       Impact factor: 5.432

6.  Changes in suppressor, helper, and B-cell functions in aging mice.

Authors:  J J Liu; M Segre; D Segre
Journal:  Cell Immunol       Date:  1982-01-15       Impact factor: 4.868

7.  Changes in lymphocyte subsets and immune competence in very advanced age.

Authors:  L Lehtonen; J Eskola; O Vainio; A Lehtonen
Journal:  J Gerontol       Date:  1990-05

8.  Regional dichotomy of interleukin-4 and -5 regulation of senescent B cell responses specific for cholera toxin in Peyer's patches, lamina propria, and mesenteric lymph nodes.

Authors:  J A Haq; M R Szewczuk
Journal:  Reg Immunol       Date:  1993 Jan-Feb

9.  Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity.

Authors:  C Nicoletti; C Borghesi-Nicoletti; X H Yang; D H Schulze; J Cerny
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

10.  Lymphokines and aging: interleukin-2 production and activity in aged animals.

Authors:  M L Thoman; W O Weigle
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

View more
  26 in total

1.  Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization.

Authors:  J W Dorigo-Zetsma; R P Verkooyen; H P van Helden; H van der Nat; J M van den Bosch
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

Authors:  Thanh Q Tran; Carolyn Z Grimes; Dejian Lai; Catherine L Troisi; Lu-Yu Hwang
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

Review 3.  Epidemiology of perforated colonic diverticular disease.

Authors:  C R Morris; I M Harvey; W S L Stebbings; C T M Speakman; H J Kennedy; A R Hart
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

4.  P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis.

Authors:  Gowrisankar Rajam; Mathieu Bangert; Gabrielle M Hammons; Nikkol Melnick; George M Carlone; Jacquelyn S Sampson; Edwin W Ades
Journal:  Clin Vaccine Immunol       Date:  2010-09-15

5.  Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine.

Authors:  George Hui; Caryn Hashimoto
Journal:  Vaccine       Date:  2007-07-19       Impact factor: 3.641

6.  B cells from aged mice exhibit reduced apoptosis upon B-cell antigen receptor stimulation and differential ability to up-regulate survival signals.

Authors:  C L Montes; B A Maletto; E V Acosta Rodriguez; A Gruppi; M C Pistoresi-Palencia
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

7.  Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.

Authors:  Douglas M Heithoff; Elena Y Enioutina; Diana Bareyan; Raymond A Daynes; Michael J Mahan
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

8.  Naive CD4 T cells from aged mice show enhanced death upon primary activation.

Authors:  Hamid Mattoo; Matthew Faulkner; Usha Kandpal; Rituparna Das; Virginia Lewis; Anna George; Satyajit Rath; Jeannine M Durdik; Vineeta Bal
Journal:  Int Immunol       Date:  2009-09-11       Impact factor: 4.823

9.  Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously.

Authors:  Rajiv Sharma; Clas Ahlm; Lars Ostergaard; Anthony Dowell; Clément Tran; Stéphane Thomas; Cécile Eymin
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 10.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.